Tradestie Institutional Equity Comparison Engine
RYOJ vs SBC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SBC Overall Edge
SBC Captures Institutional Edge (3โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SBC Medical Group Holdings Incorporated Common Stock (SBC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RYOJ trades at N/M Forward P/E with -8.1% operating margin (-34.3% YoY revenue) versus SBC at 10.2x Forward P/E and 39.9% operating margin (+35.1% YoY). In options structure, RYOJ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
SBC
RYOJ N/M vs SBC 10.2x Fwd P/E
Growth & Margin Winner
SBC
Op Margin -8.1% vs 39.9% ยท YoY -34.3% vs +35.1%
Momentum & Technical Winner
SBC
1Y -49.0% vs +76.7% ยท 52W Pos 10% vs 61%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RYOJ
NASDAQ
rYojbaba Co., Ltd. Common Shares
Services-Management Consulting Services
$2.23
-0.89% 1D
Market Cap
$26.0M
1M Return
-11.51%
1Y Return
-48.97%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 23.0
Fund 50.0
Flow 50.0
Mom 64.0
SBC
NASDAQ
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.60
-10.69% 1D
Market Cap
$643.2M
1M Return
+1.08%
1Y Return
+76.66%
Forward P/E
10.2x
Unified AI Score
38.7 / 100
SELL
Tech 15.0
Fund 29.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RYOJ -48.97%
SBC +76.66%
Spread: +126.32 pp (SBC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RYOJ TTM Op. Margin: -8.1%
SBC TTM Op. Margin: 39.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RYOJ vs SBC. Trailing 12-month operating profitability (RYOJ -8.1% vs SBC 39.9%) and valuation multiples (RYOJ N/M vs SBC 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RYOJ | SBC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $26.0M | $643.2M | Larger Scale | SBC |
| Trailing P/E Ratio Valuation | N/M | 12.3x | Lower Multiple | SBC |
| Forward P/E Ratio Valuation | N/M | 10.2x | Lower Multiple | SBC |
| Revenue Growth (YoY) Growth | -34.3% | +35.1% | Higher Growth | SBC |
| Operating Margin (TTM) Profitability | -8.1% | 39.9% | Higher Margin | SBC |
| Net Profit Margin Profitability | 1.3% | 27.3% | Higher Margin | SBC |
| Return on Equity (ROE) Capital Efficiency | 2.8% | 19.3% | Higher ROE | SBC |
| 52-Week Range Position Momentum | 10% ($2โ$8) | 61% ($3โ$7) | Stronger Trend | SBC |
| Beta / 30D Volatility Risk Regime | 1.68ฮฒ ยท 92% Vol | 0.80ฮฒ ยท 156% Vol | Lower Realized Risk | RYOJ |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 38.7 / 100 (SELL) | Higher Composite | RYOJ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RYOJ vs SBC Buy Guide
RYOJ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SBC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RYOJ nor SBC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.